Laurantis

Laurentis Energy Partners is a leading provider of nuclear services and a major producer of medical isotopes for the global healthcare industry. A subsidiary of Ontario Power Generation, the company utilizes its unique access to CANDU nuclear reactors to produce critical isotopes such as Lutetium-177, Molybdenum-99, and Yttrium-90. These isotopes are essential components in targeted radionuclide therapies and diagnostic imaging for various forms of cancer. Laurentis operates in collaboration with global radiopharmaceutical leaders to ensure a reliable supply chain for life-saving oncology treatments. Headquartered in Ontario, Canada, Laurentis operates at the intersection of nuclear technology and life sciences to address global shortages of critical medical materials.